scispace - formally typeset
Y

Yoshikazu Mizoguchi

Researcher at Fujita Health University

Publications -  78
Citations -  1529

Yoshikazu Mizoguchi is an academic researcher from Fujita Health University. The author has contributed to research in topics: Lymphoma & Carcinoma. The author has an hindex of 20, co-authored 77 publications receiving 1432 citations.

Papers
More filters
Journal ArticleDOI

Enhancement of in vivo anticancer effects of cisplatin by incorporation inside single-wall carbon nanohorns.

TL;DR: It is thought that the CDDP released from SWNHox realized high concentrations locally at the cells in vitro and in the tissues in vivo and could efficiently attack the tumor cells.
Journal ArticleDOI

Anaplastic large cell lymphoma : a distinct molecular pathologic entity : a reappraisal with special reference to p80(NPM/ALK) expression

TL;DR: This study clearly demonstrated that the immunohistochemical detection of p80 is of a crucial importance in delineating the biologically distinct entity of "primary classical ALCL" from various diseases that show morphologic and immunophenotypic overlap, including HD and HD-like ALCL.
Journal ArticleDOI

Malignant histiocytosis‐like B‐cell lymphoma, a distinct pathologic variant of intravascular lymphomatosis: a report of five cases and review of the literature

TL;DR: Five Japanese patients with MH‐like BCL appear to form a peculiar variant of IVL, characterized by bone marrow involvement at presentation, haemophagocytic syndrome, and a rapidly aggressive clinical course, but rarely neurological complications or skin lesions, which may merit separate consideration.
Journal ArticleDOI

Clinicopathologic study of nasal T/NK‐cell lymphoma among the Japanese

TL;DR: The concept that most cases of NTCL are identified as tumors with T/NK‐cell characteristics and EBV association, distincity different from other peripheral T‐cell lymphomas is supported.
Journal ArticleDOI

Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients.

TL;DR: The expression of cytotoxic granule-associated proteins has been reported in some T-cell or natural killer (NK)-cell lymphomas of mostly extranodal origin, but rarely of nodal origin except for anaplastic large cell lymphoma (ALCL) and Hodgkin's disease (HD).